Clinical Trials Browser

Phase 1/2 × Disease × tislelizumab × Clear all

NCT07244705 2025-11-24

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Phase 1/2 Recruiting

Gastrointestinal

Disease, Colorectal Neoplasms